Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA | Benzinga
Explore Athira Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATHA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Athira Pharma (ATHA) stock?
You can purchase shares of Athira Pharma (NASDAQ:ATHA) through any online brokerage.
Who are Athira Pharma (ATHA) competitors?
Other companies in Athira Pharma’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the forecast, or price target, for Athira Pharma (ATHA) stock?
Athira Pharma has a consensus price target of $12.70.
What is the current price for Athira Pharma (ATHA)?
The stock price for Athira Pharma (NASDAQ: ATHA) is $0.437323 last updated February 27, 2025 at 10:55 AM EST.
Does Athira Pharma (ATHA) pay a dividend?
There are no upcoming dividends for Athira Pharma.
When is Athira Pharma (NASDAQ:ATHA) reporting earnings?
Athira Pharma’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Athira Pharma (ATHA) going to split?
There is no upcoming split for Athira Pharma.
What sector and industry does Athira Pharma (ATHA) operate in?
Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.